sever
acut
respiratori
syndrom
sar
newli
emerg
infecti
diseas
effect
vaccin
avail
studi
compar
immunogen
protect
efficaci
recombin
protein
correspond
differ
domain
sarscoronaviru
spike
protein
trimer
recombin
protein
creat
fuse
foldon
domain
deriv
bacteriophag
carboxytermini
individu
domain
spike
protein
fulllength
ectodomain
spike
protein
fulllength
ectodomain
fuse
foldon
sfoldon
domain
domain
antigen
elicit
compar
antibodi
titer
measur
elisa
sfoldon
induc
significantli
higher
titer
neutral
antibodi
protein
elicit
viru
neutral
antibodi
test
mous
viru
replic
model
mice
vaccin
sfoldon
complet
protect
ever
acut
respiratori
syndrom
sar
associ
coronaviru
sarscov
emerg
infecti
pathogen
zoonot
origin
although
new
case
sar
report
sinc
sar
potenti
reemerg
anim
reservoir
accident
intent
releas
therefor
develop
effect
vaccin
highli
desir
prevent
contain
futur
outbreak
sar
differ
vaccin
strategi
explor
sar
includ
inactiv
wholeviru
dna
recombin
live
vector
attenu
viru
subunit
vaccin
shown
induc
neutral
protect
respons
howev
safeti
issu
relat
either
vaccin
product
use
human
made
subunit
vaccin
favor
strategi
genom
sarscov
encod
four
structur
protein
includ
spike
membran
envelop
e
nucleocapsid
n
nonstructur
protein
protein
kda
transmembran
protein
respons
receptor
bind
via
receptorbind
domain
locat
region
well
virusmembran
fusion
tissu
tropism
involv
region
protein
main
compon
viru
induc
neutral
antibodi
viru
thu
consid
main
target
sar
vaccin
present
studi
compar
fulllength
ectodomain
protein
fragment
domain
respect
immunogen
protect
viral
infect
mice
nativ
state
protein
trimer
howev
ectodomain
express
recombin
protein
eukaryot
system
protein
exist
predominantli
monomer
form
make
trimer
recombin
spike
protein
exploit
acid
sequenc
call
foldon
domain
identifi
bacteriophag
fibritin
protein
compar
immunogen
protect
efficaci
monomer
fulllength
spike
ectodomain
monomer
domain
trimer
form
gener
fusion
foldon
domain
carboxi
termini
protein
result
show
recombin
elicit
neutral
antibodi
fulllength
ectodomain
ctermin
foldon
sfoldon
induc
higher
level
neutral
antibodi
construct
nevertheless
sfoldon
protect
mice
viral
challeng
insect
cell
maintain
serumfre
insect
cultur
medium
allel
tm
biotechnolog
high
five
cell
cultur
excel
tm
medium
safc
bioscienc
cell
cultur
co
dulbecco
modifi
eagl
medium
dmem
invitrogen
supplement
fb
invitrogen
uml
penicillin
lgml
streptomycin
baculoviru
transfer
vector
bd
bioscienc
linear
baculoviru
dna
ab
vector
proeasi
tm
sigma
diamond
bac
tm
dna
encod
thrombin
cleavag
site
linker
follow
bacteriophag
foldon
domain
plu
histidin
nkllvprgspgsgyipeaprdgqayvrkdgewvl
stflghhhhhhhhh
underlin
amino
acid
residu
foldon
peptid
chemic
synthes
hind
iii
restrict
site
end
respect
dna
fragment
encod
amino
acid
aa
spike
protein
sarscov
strain
urbani
without
sequenc
encod
histidin
carboxi
terminu
amplifi
pcr
vector
contain
fulllength
gene
codonoptim
express
mammalian
cell
gene
fragment
tag
ligat
bamhi
site
give
pacgp
gene
without
tag
colig
foldon
dna
fragment
use
bamh
hind
iii
site
result
pacgpsfoldon
dna
fragment
encod
aa
domain
aa
domain
spike
protein
amplifi
pcr
use
replac
sequenc
pacgp
pacgpsfoldon
gener
plasmid
respect
recombin
baculovirus
made
cotransfect
plasmid
linear
baculoviru
dna
cell
accord
manufactur
instruct
protein
product
supernat
cultur
high
five
insect
cell
infect
recombin
virus
harvest
concentr
bufferexchang
phosphatebuff
salin
pb
ph
pellicon
xl
devic
cutoff
size
kilodalton
labscal
tff
system
millipor
subject
chromatographi
purif
ninta
column
biolog
lp
chromatographi
system
biorad
protein
elut
linear
gradient
imidazol
pb
dialyz
pb
concentr
appropri
use
amicon
ultra
centrifug
filter
devic
millipor
protein
concentr
determin
use
dc
protein
assay
biorad
bovin
gamma
globulin
standard
protein
store
use
analysi
protein
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
western
blot
perform
bistri
nupagem
gel
kit
invitrogen
accord
manufactur
instruct
purifi
protein
dilut
wvol
sucros
pb
ad
top
sucros
gradient
prepar
pb
centrifug
ti
rotor
rpm
h
fraction
collect
top
gradient
fraction
analyz
sdspage
western
blot
analysi
use
mous
monoclon
antihi
tag
antibodi
novagen
balbc
mice
week
old
n
per
group
immun
subcutan
sc
intramuscularli
im
lg
purifi
recombin
protein
formul
titermax
gold
adjuv
aluminum
hydroxid
gel
alum
plu
monophosphoryl
lipid
mpl
sigma
day
except
indic
formul
prepar
accord
manufactur
instruct
titermax
one
volum
protein
pb
emulsifi
one
volum
adjuv
alummpl
protein
pb
mix
alum
gel
plu
mpl
rotat
overnight
dose
deliv
anim
control
group
receiv
pb
adjuv
day
blood
sampl
collect
tail
bleed
indic
time
point
sera
prepar
immuno
maxisorp
plate
nunc
coat
per
well
recombin
protein
lgml
dilut
pb
overnight
plate
block
per
well
blocker
tm
casein
pb
thermo
scientif
h
room
temperatur
mous
serum
first
dilut
blocker
tm
casein
serial
dilut
serum
dilut
ad
well
incub
room
temperatur
h
wash
plate
three
time
pb
contain
tween
pbst
peroxidaseconjug
goat
antimous
igg
sothern
biotech
dilut
pbst
ad
detect
bound
antibodi
peroxidas
substrat
solut
kpl
contain
hydrogen
peroxid
use
develop
plate
absorb
read
nm
precis
micropl
reader
molecular
devic
mous
serum
treat
min
inactiv
complement
dilut
dmem
serial
dilut
serum
made
tissu
cultur
plate
ad
dilut
serum
equal
volum
dmem
carri
dilut
equal
volum
sarscov
urbani
strain
tcid
ad
mixtur
incub
h
room
temperatur
mixtur
transfer
onto
vero
cell
serum
test
four
replic
dilut
cell
cultur
incub
examin
cytopath
effect
cpe
microscop
day
later
highest
dilut
serum
prevent
cpe
cell
cultur
well
report
antibodi
neutral
titer
anim
studi
conduct
facil
bioqual
inc
accord
approv
institut
anim
care
use
committe
us
food
drug
administr
bioqual
day
follow
last
immun
anesthet
mice
intranas
inocul
tcid
sarscov
strain
urbani
total
volum
mice
euthan
day
follow
challeng
lung
harvest
store
viru
titer
determin
vero
cell
monolay
describ
previous
briefli
whole
lung
tissu
mous
homogen
manual
steril
microcentrifug
tube
plastic
pestl
mix
appropri
volum
dulbecco
modifi
eagl
medium
dmem
invitrogen
usa
make
suspens
homogen
centrifug
benchtop
centrifug
top
speed
min
supernat
store
aliquot
use
viru
titer
determin
supernat
ad
well
contain
monolay
vero
cell
seed
tissuecultur
plate
previou
day
seri
dilut
supernat
assay
four
replic
well
per
dilut
result
evalu
day
inocul
viral
titer
calcul
reedmuench
method
student
test
use
analyz
differ
mean
valu
group
p
valu
smaller
consid
statist
signific
six
recombin
protein
design
tag
carboxytermin
end
allow
metalchel
affin
purif
fig
secret
cultur
medium
confirm
western
blot
analysi
supplementari
fig
supplementari
materi
avail
onlin
wwwliebertpubcomvim
protein
could
purifi
henc
includ
subsequ
experi
protein
purifi
near
homogen
determin
sdspage
fig
determin
sfoldon
form
trimer
perform
ultracentrifug
sucros
gradient
compar
motil
sfoldon
shown
figur
upper
panel
sfoldon
sediment
higher
concentr
sucros
peak
indic
sfoldon
form
oligom
posit
sfoldon
gradient
rel
kd
protein
marker
suggest
trimer
state
note
howev
small
proport
molecul
sediment
trimer
sfoldon
locat
suggest
may
also
form
trimer
although
much
lower
effici
compar
sfoldon
addit
sfoldon
also
found
bottom
fraction
indic
fraction
sfoldon
molecul
form
aggreg
appear
could
also
form
trimer
fig
lower
panel
trimer
format
analysi
sfoldon
ten
microgram
sfoldon
overlaid
step
sucros
gradient
run
rotor
rpm
h
fraction
collect
top
tube
fraction
subject
nupagem
follow
western
blot
analysi
antihi
tag
antibodi
posit
protein
standard
aldolas
kd
thyroglobulin
kd
indic
li
et
al
immunogen
recombin
protein
first
test
group
balbc
mice
n
administ
individu
protein
subcutan
sc
rout
titermax
gold
adjuv
waterinoil
adjuv
day
day
day
ten
day
third
dose
sera
obtain
time
euthanasia
mice
antibodi
level
measur
elisa
use
cognat
protein
coat
antigen
shown
figur
sfoldon
elicit
geometr
mean
antibodi
titer
equival
greater
elicit
geometr
mean
antibodi
titer
slightli
higher
sera
test
viru
neutral
activ
vitro
fig
sera
mice
immun
compar
level
viru
neutral
activ
geometr
mean
neutral
titer
respect
interestingli
sera
mice
immun
sfoldon
show
strongest
neutral
activ
geometr
mean
neutral
titer
titer
higher
sera
mice
immun
respect
differ
statist
signific
p
sfoldon
versu
respect
neutral
activ
detect
sera
mice
immun
next
test
immunogen
antigen
formul
potenti
relev
human
use
antigen
mix
alum
gel
mpl
administ
either
sc
intramuscular
im
rout
group
bablc
mice
n
day
day
day
sera
mice
also
high
elisa
titer
although
lower
titermax
use
fig
addit
antibodi
titer
higher
im
group
sc
group
fig
immunogen
recombin
protein
serum
elisa
antibodi
titer
viru
neutral
titer
mice
immun
recombin
spike
protein
adjuv
titermax
mice
n
immun
pb
recombin
protein
mix
titermax
day
sera
prepar
sacrif
mice
day
end
point
elisa
titer
determin
plate
coat
cognat
antigen
viru
neutral
activ
measur
vero
cell
b
c
mice
immun
three
time
subcutan
n
intramuscularli
n
recombin
protein
formul
alummpl
elisa
titer
sera
determin
cognat
antigen
geometr
mean
plu
standard
deviat
shown
group
mous
sera
differ
statist
signific
p
p
p
p
sfoldon
p
fig
test
protect
efficaci
recombin
protein
mous
model
induc
detect
viru
neutral
activ
antigen
test
efficaci
mice
group
mice
immun
im
sfoldon
adjuv
alum
mpl
pb
plu
adjuv
alon
control
day
day
day
delay
product
live
viru
challeng
fourth
dose
given
day
mice
bled
day
week
last
dose
vaccin
plasma
antibodi
level
measur
elisa
plate
coat
cognat
antigen
mice
receiv
recombin
spike
protein
antigen
high
antibodi
titer
fig
insuffici
volum
sera
avail
neutral
assay
day
week
follow
last
dose
mice
challeng
intranas
tcid
sarscov
one
mous
group
die
process
inocul
like
due
anesthet
mice
appear
normal
throughout
challeng
experi
day
post
challeng
mice
sacrif
lung
homogen
viru
load
determin
mice
group
receiv
pb
plu
alummpl
high
viral
load
lung
sharp
contrast
mice
group
receiv
recombin
spike
protein
vaccin
detect
viru
lung
fig
protein
present
trimer
viru
interest
examin
whether
trimer
protein
superior
monom
term
immunogen
protect
efficaci
recombin
trimer
fulllength
protein
report
highli
immunogen
abl
elicit
efficaci
protect
immun
respons
howev
fulllength
protein
contain
transmembran
domain
make
impract
vaccin
product
overcom
problem
made
secret
recombin
protein
fuse
foldon
domain
deriv
phage
fibritin
ectodomain
domain
foldon
shown
promot
trimer
number
recombin
protein
collagen
fiber
studi
recombin
protein
foldon
sfoldon
form
trimer
oligom
predict
directli
involv
format
trimer
spike
protein
like
trimer
state
seen
present
studi
structur
three
monom
simpli
bound
togeth
foldon
although
sfoldon
similarli
tend
form
aggreg
freezingthaw
major
fraction
sfoldon
appear
retain
trimer
state
unknown
present
studi
extent
trimer
sfoldon
structur
similar
nativ
spike
protein
howev
nevertheless
compar
immunogen
potenc
induc
viru
li
et
al
neutral
antibodi
sfoldon
show
significantli
stronger
potenc
induct
neutral
antibodi
sera
mice
immun
sfoldon
higher
titer
compar
mice
immun
inde
sfoldon
potent
immunogen
among
five
recombin
protein
test
studi
principl
behind
phenomenon
yet
elucid
probabl
foldon
play
role
maintain
nativ
conform
neutral
epitop
trimer
immunogen
altern
trimer
protein
effici
present
commit
b
lymphocyt
induc
higher
level
antibodi
number
differ
anim
model
describ
sarscov
none
complet
recapitul
sarscov
patholog
human
consid
cost
avail
eas
use
viru
replic
murin
model
still
repres
conveni
model
initi
proofofconcept
evalu
vaccin
candid
test
viru
infect
mous
model
four
immunogen
sfoldon
fulli
protect
mice
viru
challeng
differ
observ
four
immunogen
test
perhap
mice
given
four
dose
high
antibodi
level
challeng
howev
given
much
stronger
potenc
induc
neutral
antibodi
construct
sfoldon
might
confer
accept
level
protect
fewer
dose
construct
would
relev
use
human
deserv
studi
domain
sarscov
mediat
membran
fusion
viral
infect
henc
potenti
target
protect
antibodi
howev
report
regard
presenc
neutral
epitop
protect
role
antibodi
inconsist
sever
studi
suggest
domain
contain
neutral
epitop
immun
escherichia
coli
express
chemic
synthes
peptid
elicit
neutral
antibodi
immun
plasmid
encod
domain
also
report
induc
neutral
antibodi
rabbit
contrari
also
report
show
recombin
domain
could
induc
neutral
antibodi
result
demonstr
recombin
highli
immunogen
could
induc
neutral
antibodi
domain
coronavirus
also
fail
induc
neutral
antibodi
taken
togeth
like
protect
epitop
exist
immunodomin
conclus
studi
corrobor
recombin
protein
base
either
domain
fulllength
ectodomain
protein
suitabl
vaccin
candid
importantli
suggest
fulllength
ectodomain
engin
form
secret
trimer
may
superior
form
sar
subunit
vaccin
secret
protein
would
like
easier
produc
nativ
membran
protein
